Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

NCT04874038 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1602

Enrollment

OTHER

Sponsor class

Conditions

Post-mastectomy Pain Syndrome
Breast Cancer
Pain, Postoperative
Pain, Chronic

Interventions

DRUG: Lidocaine 20mg/ml
DRUG: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]